|Articles|October 18, 2021
Curia
Author(s)Curia
End-to-end contract research, development and manufacturing services for large and small molecules.
Curia, formerly AMRI, is a leading contract research, development and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s more than 3,700 employees at 29 locations across the U.S., Europe and Asia help its customers advance from curiosity to cure.
Learn more at
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
Generative AI and Adaptive Trials Shape Future Biotech Development
5